Atlas Trials

Evaluation of the Effect of Wismemo on Alzheimer's Dementia Patients

Clinical trial NCT04094129 · WITHDRAWN

Trial details

NCT number
NCT04094129
Sponsor
GenMont Biotech Incorporation
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2020-01-01
Primary completion
2020-02-11
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.